Loss of Activity of Plasma Platelet-Activating Factor Acetylhydrolase Due to a Novel Gln281→Arg Mutation
- 1 July 1997
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 236 (3), 772-775
- https://doi.org/10.1006/bbrc.1997.7047
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.JCI Insight, 1996
- Anti-inflammatory properties of a platelet-activating factor acetylhydrolaseNature, 1995
- Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsisCritical Care Medicine, 1994
- Novel leukocyte agonists are released by endothelial cells exposed to peroxide.Journal of Biological Chemistry, 1992
- Cloning by functional expression of platelet-activating factor receptor from guinea-pig lungNature, 1991
- Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitisThe Journal of Pediatrics, 1990
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.JCI Insight, 1988
- Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.Journal of Biological Chemistry, 1987